Exelixis Competitors and Similar CompaniesClear all

Exelixis's competitors and similar companies include Deciphera Pharmaceuticals and NiKang Therapeutics.
Exelixis
Exelixis
Exelixis a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
NiKang Therapeutics
NiKang Therapeutics
NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
Founding Date
Founding Date
1994
Founding Date
2003
Founding Date
2017
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Alameda, US HQ
Locations
Waltham, US HQ
Lawrence, US
Locations
Wilmington, US HQ
Employees
Employees
61727% increase
Employees
35037% increase
Employees
40
Valuation ($)
Valuation ($)
6.9 b
Valuation ($)
1.2 b
Valuation ($)
N/A
Twitter followers
Twitter followers
5.8 k
Twitter followers
783
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.9
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$1.8b (FY, 2023)
Revenue (est.)
$163.4m (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$72.5m (FY, 2023)
Cost of goods
$3.7m (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
$1.8b (FY, 2023)
Gross profit
$159.6m (FY, 2023)
Gross profit
N/A
Net income
Net income
$207.8m (FY, 2023)
Net income
($194.9m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 714m
Total funding raised
$ 200m
For sources of this data, please see the company profile

View Company Profiles

Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.

View company
NiKang Therapeutics
HQ
Wilmington, US
Employees
40

NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.

View company